Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 160.92 million compared to CNY 95.8 million a year ago. Revenue was CNY 160.92 million compared to CNY 95.8 million a year ago.

Net income was CNY 35.07 million compared to CNY 19.53 million a year ago. Basic earnings per share from continuing operations was CNY 0.32 compared to CNY 0.18 a year ago. Diluted earnings per share from continuing operations was CNY 0.32 compared to CNY 0.18 a year ago.